GLOBAL BLOOD THERAPEUTICS IN's ticker is GBT and the CUSIP is 37890U108. A total of 159 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q4 2017. The put-call ratio across all filers is 0.50 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2019 | $921,000 | -0.5% | 17,500 | 0.0% | 0.05% | -6.9% |
Q1 2019 | $926,000 | +0.2% | 17,500 | -22.2% | 0.06% | -18.3% |
Q4 2018 | $924,000 | +62.1% | 22,500 | +50.0% | 0.07% | +129.0% |
Q3 2018 | $570,000 | -15.9% | 15,000 | 0.0% | 0.03% | -18.4% |
Q2 2018 | $678,000 | -12.3% | 15,000 | -6.2% | 0.04% | -5.0% |
Q1 2018 | $773,000 | +44.5% | 16,000 | +17.6% | 0.04% | +60.0% |
Q4 2017 | $535,000 | -60.7% | 13,600 | -83.5% | 0.02% | -55.4% |
Q2 2016 | $1,363,000 | – | 82,200 | – | 0.06% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Fernwood Investment Management, LLC | 383,702 | $14,581,000 | 7.71% |
Perceptive Advisors | 5,148,910 | $195,658,000 | 5.23% |
Grace Capital | 312,514 | $11,876,000 | 4.65% |
NEXTHERA CAPITAL LP | 549,231 | $20,871,000 | 4.00% |
Asymmetry Capital Management, L.P. | 103,449 | $3,931,000 | 3.63% |
Camber Capital Management LP | 2,075,000 | $78,850,000 | 3.37% |
Casdin Capital, LLC | 440,000 | $16,720,000 | 2.03% |
EMORY UNIVERSITY | 53,951 | $2,050,000 | 1.34% |
ArchPoint Investors | 129,435 | $4,919,000 | 1.34% |
Ghost Tree Capital, LLC | 150,000 | $5,700,000 | 1.21% |